Genmab A/S (GNMSF) Non-Current Assets (2018 - 2026)
Genmab A's (GNMSF) quarterly Non-Current Assets came in at $9.8 billion in Q1 2026, up 284.58% YoY from $2.5 billion in Q1 2025, and down 1.85% on a QoQ basis from $10.0 billion in Q4 2025.
Genmab A/S (GNMSF) Non-Current Assets (2018 - 2026) Analysis & Trends
Genmab A (GNMSF) has 7 years of Non-Current Assets data on file, last reported at $9.8 billion in Q1 2026.
- Quarterly Non-Current Assets rose 284.58% year-over-year to $9.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 billion (up 75.02% YoY) and the FY2025 annual result came in at $10.0 billion, up 297.3% from the prior year.
- Non-Current Assets retreated to $9.8 billion in Q1 2026, from $10.0 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $10.0 billion in Q4 2025 to a low of $320.0 million in Q4 2023.
- A 4-year average of $3.7 billion and a median of $2.5 billion in 2025 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2024 — Non-Current Assets jumped 685.62% — and 2025, when it rose 6.38%.
- Tracing GNMSF's Non-Current Assets over 4 years: stood at $320.0 million in 2023, then jumped by 685.62% to $2.5 billion in 2024, then jumped by 297.3% to $10.0 billion in 2025, then fell by 1.85% to $9.8 billion in 2026.
- The last three Non-Current Assets figures came in at $9.8 billion (Q1 2026), $10.0 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.71 Bn |
| Mar 31, 2026 | 9.80 Bn |
| Dec 31, 2025 | 9.99 Bn |
| Sep 30, 2025 | 2.55 Bn |
| Jun 30, 2025 | 2.55 Bn |
| Mar 31, 2025 | 2.55 Bn |
| Dec 31, 2024 | 2.51 Bn |
| Sep 30, 2024 | 2.40 Bn |
| Mar 31, 2024 | 335.00 Mn |
| Dec 31, 2023 | 320.00 Mn |
| Sep 30, 2020 | 2,018.00 |
| Dec 31, 2019 | 1,074.00 |
| Sep 30, 2019 | 1.07 Bn |
| Dec 31, 2018 | 831.75 Mn |